B_NN
lymphocytes_NNS
from_IN
patients_NNS
with_IN
chronic_JJ
lymphocytic_JJ
leukemia_NN
contain_VBP
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
1_CD
and_CC
STAT3_NN
constitutively_RB
phosphorylated_VBN
on_IN
serine_NN
residues_NNS
._.

To_TO
explore_VB
the_DT
pathogenesis_NN
of_IN
chronic_JJ
lymphocytic_JJ
leukemia_NN
-LRB-_-LRB-
CLL_NN
-RRB-_-RRB-
,_,
we_PRP
examined_VBD
whether_IN
phosphorylation_NN
of_IN
one_CD
or_CC
more_JJR
signal_NN
transducer_NN
and_CC
activator_NN
of_IN
transcription_NN
-LRB-_-LRB-
STAT_NN
-RRB-_-RRB-
factors_NNS
was_VBD
abnormal_JJ
in_IN
cells_NNS
from_IN
CLL_NN
patients_NNS
._.

No_DT
constitutive_JJ
tyrosine_NN
phosphorylation_NN
was_VBD
detected_VBN
on_IN
any_DT
STAT_NN
in_IN
CLL_NN
cells_NNS
._.

To_TO
assess_VB
the_DT
phosphorylation_NN
of_IN
serine_NN
residues_NNS
of_IN
STAT1_NN
and_CC
STAT3_NN
in_IN
CLL_NN
cells_NNS
,_,
we_PRP
raised_VBD
antibodies_NNS
that_WDT
specifically_RB
recognize_VBP
the_DT
form_NN
of_IN
STAT1_NN
phosphorylated_VBN
on_IN
ser-727_NN
and_CC
the_DT
form_NN
of_IN
STAT3_NN
phosphorylated_VBN
on_IN
ser-727_NN
._.

We_PRP
found_VBD
that_IN
in_IN
100_CD
%_NN
of_IN
patients_NNS
with_IN
CLL_NN
-LRB-_-LRB-
n_NN
=_JJ
32_CD
-RRB-_-RRB-
,_,
STAT1_NN
and_CC
STAT3_NN
were_VBD
constitutively_RB
phosphorylated_VBN
on_IN
serine_NN
._.

This_DT
was_VBD
in_IN
contrast_NN
to_TO
normal_JJ
peripheral_JJ
blood_NN
B_NN
lymphocytes_NNS
or_CC
CD5_NN
+_JJ
-RRB-_-RRB-
B_NN
cells_NNS
isolated_VBN
from_IN
tonsils_NNS
,_,
in_IN
which_WDT
this_DT
phosphorylation_NN
was_VBD
absent_JJ
._.

Serine_NN
phosphorylation_NN
of_IN
STAT1_NN
and_CC
STAT3_NN
was_VBD
seen_VBN
occasionally_RB
in_IN
other_JJ
leukemias_NNS
,_,
but_CC
it_PRP
was_VBD
a_DT
universal_JJ
finding_NN
only_RB
in_IN
CLL_NN
._.

The_DT
serine_NN
phosphorylation_NN
of_IN
these_DT
STATs_NNS
was_VBD
a_DT
continuous_JJ
process_NN
,_,
as_IN
incubation_NN
of_IN
CLL_NN
cells_NNS
with_IN
the_DT
kinase_NN
inhibitor_NN
H7_NN
led_VBD
to_TO
the_DT
dephosphorylation_NN
of_IN
these_DT
serine_NN
residues_NNS
._.

The_DT
STAT_NN
serine_NN
kinase_NN
in_IN
CLL_NN
cells_NNS
has_VBZ
not_RB
been_VBN
identified_VBN
,_,
and_CC
appears_VBZ
to_TO
be_VB
neither_CC
mitogen-activated_JJ
protein_NN
kinase_NN
nor_CC
pp70_NN
-LRB-_-LRB-
s6k_NN
-RRB-_-RRB-
._.

In_IN
summary_NN
,_,
the_DT
constitutive_JJ
serine_NN
phosphorylation_NN
of_IN
STAT1_NN
and_CC
STAT3_NN
is_VBZ
present_JJ
in_IN
all_DT
CLL_NN
samples_NNS
tested_VBN
to_TO
date_NN
,_,
although_IN
the_DT
physiologic_JJ
significance_NN
of_IN
this_DT
modification_NN
remains_VBZ
to_TO
be_VB
determined_VBN
._.

